{"id":124,"date":"2019-01-29T15:23:13","date_gmt":"2019-01-29T06:23:13","guid":{"rendered":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol-test\/?page_id=124"},"modified":"2025-09-08T13:55:55","modified_gmt":"2025-09-08T04:55:55","slug":"eibunsousetsu","status":"publish","type":"page","link":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/publications\/eibunsousetsu\/","title":{"rendered":"\u82f1\u6587\u7dcf\u8aac"},"content":{"rendered":"<p>(*corresponding author)\uff08\u00a7\uff1dequally contribution\uff09<\/p>\n<h4>2025<\/h4>\n<ol>\n<li>Sakurai Y, Yu L, Matsuda A, Maishi N\u00a0, <u>Hida K*<\/u>\uff1aVascular Inflammation and Cancer Malignancy, <strong><em>J Oral Biosci <\/em><\/strong>\u00a02025 Jun;67(2):100671.\u00a0doi: 10.1016\/j.job.2025.100671.\u00a0Epub 2025 May 20.<\/li>\n<\/ol>\n<h4>2024<\/h4>\n<ol>\n<li><u>Hida K<\/u>*<u>, <\/u>Maishi N, Matsuda A, Yu L: Beyond starving cancer, antiangiogenic therapy, <strong><em>J Med Ultrasonic<\/em><\/strong>, 2024; 51(4). doi:10.1007\/s10396-023-01310-1<\/li>\n<li>Takakura Y, Hanayama R, Akiyoshi K, Futaki S, Hida K, Ichiki T, IshiiWatabe A,Kuroda M, Maki K, Miura Y, Okada Y, Seo N, Takeuchi T, Yamaguchi T, Yoshioka Y: Quality and Safety Considerations for Therapeutic Products Based on ExtracellularVesicles, Pharmaceutical Research, 2024, doi.org\/10.1007\/s11095-024-03757-4<\/li>\n<\/ol>\n<h4>2023<\/h4>\n<ol>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Morimoto M, Maishi N, <\/span><span style=\"font-weight: 400\">Hida K<\/span><span style=\"font-weight: 400\">: Acquisition of drug resistance in endothelial cells by tumor-derived extracellular vesicles and cancer progression, <\/span><i><span style=\"font-weight: 400\"><strong>Cancer Drug Resistance<\/strong>, <\/span><\/i><span style=\"font-weight: 400\">2023<\/span><span style=\"font-weight: 400\">, \u00a0doi: 10.20517\/cdr.2023.121.<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Yu Li, Maishi N, Matsuda A, <\/span><span style=\"font-weight: 400\">Hida K<\/span><span style=\"font-weight: 400\">*: The functional network of biglycan: a new frontier in tumor progression, <\/span><b><i>Proteoglycan Res<\/i><\/b><span style=\"font-weight: 400\">, 2023\uff08IF=0) doi: 10.1002\/pgr2.11<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Haruhisa Watanabe , Nako Maishi, Marie Hoshi-Numahata, Mai Nishiura, Atsuko Nakanishi-Kimura, <\/span><span style=\"font-weight: 400\">Kyoko Hida<\/span><span style=\"font-weight: 400\">\u00a0and Tadahiro Iimura*: Skeletal-Vascular Interactions in Bone Development, Homeostasis, and Pathological Destruction, <\/span><b><i>Int. J. Mol. Sci<\/i><\/b><span style=\"font-weight: 400\">. 2023, 24, 10192\uff08IF= 6.132) doi:10.3390\/ijms241310912<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Hida K, <\/span><span style=\"font-weight: 400\">Maishi N, Matsuda A, Yu L: Beyond starving cancer, antiangiogenic therapy, <\/span><b><i>J Med Ultrasonic<\/i><\/b><span style=\"font-weight: 400\">, 2023\uff08IF= 1.457 \uff09\u00a0 doi:10.1007\/s10396-023-01310-1<\/span><\/li>\n<\/ol>\n<h4>2022<\/h4>\n<ol>\n<li><span style=\"font-weight: 400\">Hida K, <\/span><span style=\"font-weight: 400\">Maishi N, Matsuda A, Yu L: <\/span><span style=\"font-weight: 400\">Beyond starving cancer, antiangiogenic therapy, <\/span><b><i>J Med Ultrasonic<\/i><\/b><span style=\"font-weight: 400\">, in press<\/span><\/li>\n<li>Lucas Treps, Ann Ager and Kyoko <u>Hida K:<\/u> Editorial:Tumor Vessels as Directors of the Tumor Microenvironment: New Findings, Current Challenges &amp; Perspectives, <strong><em>Front. Cell Dev.<\/em><\/strong> <strong><em>Biol.<\/em><\/strong> Volume 10, Article 885670, March 2022<\/li>\n<li><u>Hida K<\/u>, Maishi N, Takeda R, Hida Y: Metastasis, \u201cThe Roles of Tumor Endothelial Cells in Cancer Metastasis\u201d, Exon Publications, Mar 13, 2022<\/li>\n<\/ol>\n<h4>2021<\/h4>\n<ol>\n<li>George N.Tzanakakis, Eirini-Maria Giatagana, Aikaterini Berdiaki, Ioanna Spyridaki, <u>Hida K<\/u>, Monica Neagu, Aristidis M. Tsatsakis, and Dragana Nikitovic *: The role of IGF\/IGF-IR-signaling and extracellular matrix effectors in sarcoma pathogenesis, <strong><em>Cancers<\/em><\/strong>, 13(10), 2478, 2021<\/li>\n<\/ol>\n<h4>2020<\/h4>\n<ol>\n<li>Annan DA, Kikuchi H, Maishi N, Hida Y and <u>Hida K<\/u>*: Tumor Endothelial Cell\u2014A Biological Tool for Translational Cancer Research,<strong><em> Int. J. Mol. Sci<\/em><\/strong>., 21, 3238, 2020<\/li>\n<\/ol>\n<h4>2019<\/h4>\n<ol>\n<li>Maishi N, Annan DA, Kikuchi H, Hida Y and <u>Hida K<\/u>*: Tumor endothelial heterogeneity in cancer progression, <strong><em>Cancers<\/em><\/strong>, 2019, 11(10), 1511<\/li>\n<\/ol>\n<h4>2018<\/h4>\n<ol>\n<li><u>*Hida K.<\/u>, Maishi N., Dorcas A. Annan, Hida Y.\uff1aContribution of Tumor Endothelial Cells in Cancer Progression,\u00a0<strong><em>Int J Mol Sci<\/em><\/strong>, in press<\/li>\n<li><u>*Hida K.<\/u>, Maishi N.\uff1aAbnormalities of tumor endothelial cells and cancer progression,\u00a0<strong><em>Oral Sci Int<\/em><\/strong>, 15(1), 1-6, 2018<\/li>\n<\/ol>\n<h4>2017<\/h4>\n<ol>\n<li><u>*Hida K.<\/u>, Maishi N.\uff1aAbnormalities of tumor endothelial cells and cancer progression,\u00a0<strong><em>Oral Sci Int<\/em><\/strong>, 15(1), 1-6, 2017<\/li>\n<li>Maishi N.,\u00a0<u>Hida K.<\/u>\uff1aTumor endothelial cells accelerate tumor metastasis,<strong><em>\u00a0Cancer Sci<\/em><\/strong>, 108(10), 1921-1926, 2017<\/li>\n<li><u>*Hida K<\/u>., Kikuchi H., Maishi N., Hida Y\uff1aATP-binding cassette transporters in tumor endothelial cells and resistance to metronomic chemotherapy,\u00a0<strong><em>Cancer Lett,<\/em><\/strong>\u00a0400, 305-310, 2017<\/li>\n<\/ol>\n<h4>2016<\/h4>\n<ol>\n<li><u>*Hida K<\/u>., Maishi N., Torii C., Hida Y.\uff1aTumor Angiogenesis\u2014Characteristics of Tumor Endothelial Cells,\u00a0<strong><em>Int J Clin Oncol,\u00a0<\/em><\/strong>21(2),206-212,2016<\/li>\n<li><u>*Hida K<\/u>., Maishi N., Sakurai Y., Hida Y., Harashima H.\uff1aHeterogeneity of tumor endothelial cells and drug delivery,\u00a0<strong><em>Adv Drug Deliv Rev<\/em><\/strong><strong><em>,\u00a0<\/em><\/strong>99(Pt B), 140-147, 2016<\/li>\n<\/ol>\n<h4>2013<\/h4>\n<ol>\n<li><u>*Hida K<\/u>., Ohga N., Akiyama K., Maishi N., Hida Y.\uff1aHeterogeneity of tumor endothelial cells,\u00a0<strong><em>Cancer Sci<\/em><\/strong>, 104(11), 1391-1395, 2013<\/li>\n<li><u>*Hida K<\/u><u>.<\/u>, Akiyama K., Ohga N., Maishi N., Hida Y.: Tumor endothelial cells acquire drug resistance in a tumor microenvironment,\u00a0<strong><em>J Biochem,<\/em><\/strong>153(3), 243-249, 2013<\/li>\n<\/ol>\n<h4>2011<\/h4>\n<ol>\n<li><u>*Hida K.<\/u>, Kawamoto T., Ohga N., Akiyama K., Hida Y., Shindoh M.: Altered angiogenesis in the tumor microenvironment,\u00a0<strong><em>Pathol Int,\u00a0<\/em><\/strong>61(11), 630-637, 2011<\/li>\n<\/ol>\n<h4>2010<\/h4>\n<ol>\n<li>Higashino F.,\u00a0<u>*Hida K<strong>.<\/strong><\/u>, Kitamura T., Ohga N., Shindoh M.\uff1aAberrant control of transcription and transportation of oncogenic mRNA in carcinogenesis,<strong><em>Oral Sci Int<\/em><\/strong>, 7(1), 11-18, 2010<\/li>\n<li><u>*Hida K<strong>.<\/strong><\/u>, Ohga N., Kurosu T.,Totsuka Y.andShindoh M.: Crosstalk between blood vessels and tumor microenvironment,<strong><em>Oral Sci Int<\/em><\/strong>, 7(1), 1-10, 2010<\/li>\n<\/ol>\n<h4>2009<\/h4>\n<ol>\n<li><u>*Hida K<strong>.<\/strong><\/u><strong>,<\/strong>\u00a0Ohga N.,Hida Y. and Shindoh M.: Significance of Antiangiogenic Therapy in Head and Neck Cancer-Heterogeneity of Tumor Endothelium.\u00a0<strong><em>Jpn Dent Sci Review<\/em><\/strong>, 46, 26-32, 2009<\/li>\n<\/ol>\n<h4>2008\u5e74\u4ee5\u524d<\/h4>\n<ol>\n<li>*<u>Hida K<strong>.<\/strong><\/u>, Hida Y. an Shindoh M.: Understanding Abnormality of Tumor Endothelial Cells to Develop Ideal Anti-angiogenic Therapies.\u00a0<strong><em>Cancer Sci<\/em>.<\/strong>\u00a099 (3), 459-466, 2008<\/li>\n<li><u>*Hida K<strong>.<\/strong><\/u>. and Klgsbrun M.: A new perspective on tumor endothelial cells; Unexpected Chromosome and centrosome abnormalities.\u00a0<strong><em>Cancer Res,<\/em><\/strong>\u00a065 (7), 1-4, 2005<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>(*corresponding author)\uff08\u00a7\uff1dequally contribution\uff09 2025 Sakurai Y, Yu L, Matsuda A, Maishi N\u00a0, Hida K*\uff1aVascular Inflammation and Cancer Malignancy, J Oral Biosci \u00a02025 Jun;67(2):100671.\u00a0doi: 10.1016\/j.jo&#8230;<a class=\"moretag\" href=\"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/publications\/eibunsousetsu\/\">\u7d9a\u304d\u3092\u8aad\u3080<\/a><\/p>\n","protected":false},"author":3,"featured_media":0,"parent":18,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"publications.php","meta":{"footnotes":""},"class_list":["post-124","page","type-page","status-publish","hentry"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/wp-json\/wp\/v2\/pages\/124","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/wp-json\/wp\/v2\/comments?post=124"}],"version-history":[{"count":23,"href":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/wp-json\/wp\/v2\/pages\/124\/revisions"}],"predecessor-version":[{"id":1465,"href":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/wp-json\/wp\/v2\/pages\/124\/revisions\/1465"}],"up":[{"embeddable":true,"href":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/wp-json\/wp\/v2\/pages\/18"}],"wp:attachment":[{"href":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/wp-json\/wp\/v2\/media?parent=124"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}